- Home
- MYO vs PRPO Comparison
MYO vs PRPO Comparison
Compare MYO & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- PRPO
- Stock Information
- Founded
- MYO 2004
- PRPO N/A
- Country
- MYO United States
- PRPO United States
- Employees
- MYO N/A
- PRPO N/A
- Industry
- MYO Industrial Specialties
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- MYO Health Care
- PRPO Industrials
- Exchange
- MYO Nasdaq
- PRPO Nasdaq
- Market Cap
- MYO 36.5M
- PRPO 30.2M
- IPO Year
- MYO 2017
- PRPO N/A
- Fundamental
- Price
- MYO $0.83
- PRPO $19.99
- Analyst Decision
- MYO Strong Buy
- PRPO
- Analyst Count
- MYO 3
- PRPO 0
- Target Price
- MYO $7.83
- PRPO N/A
- AVG Volume (30 Days)
- MYO 1.2M
- PRPO 12.6K
- Earning Date
- MYO 11-10-2025
- PRPO 11-17-2025
- Dividend Yield
- MYO N/A
- PRPO N/A
- EPS Growth
- MYO N/A
- PRPO N/A
- EPS
- MYO N/A
- PRPO N/A
- Revenue
- MYO $40,760,091.00
- PRPO $21,242,000.00
- Revenue This Year
- MYO $24.69
- PRPO N/A
- Revenue Next Year
- MYO $20.91
- PRPO N/A
- P/E Ratio
- MYO N/A
- PRPO N/A
- Revenue Growth
- MYO 93.08
- PRPO 27.05
- 52 Week Low
- MYO $0.79
- PRPO $3.90
- 52 Week High
- MYO $7.17
- PRPO $22.38
- Technical
- Relative Strength Index (RSI)
- MYO 36.62
- PRPO 55.39
- Support Level
- MYO $0.81
- PRPO $19.00
- Resistance Level
- MYO $0.88
- PRPO $21.41
- Average True Range (ATR)
- MYO 0.07
- PRPO 1.49
- MACD
- MYO -0.02
- PRPO -0.12
- Stochastic Oscillator
- MYO 13.10
- PRPO 56.17
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.